Cymbalta.com is a site for patients and caregivers to learn more about Cymbalta. ... Cymbalta® (duloxetine HCl) is approved for the treatment of depression and generalized anxiety disorder,

"The introduction of Cymbalta will offer physicians and patients new hope for this devastating disease." ... announced that the U.S. Food and Drug Administration (FDA) has approved ......

at that time approved Lyrica and Cymbalta work in different ways, although the mechanism of action of Lyrica is less well-understood (it is generally considered to be an anti-convulsant that also...

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. ... The recommended daily dose for Cymbalta is 60 mg.

Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).

And the more approved medications that are available, the more comfortable doctors will become in attempting to treat fibromyalgia. ... Also, Lyrica and Cymbalta are different types of medications,

Affects about 5 million Americans ... Cymbalta Approved for Fibromyalgia ... Sebelius: There Will Be Swine Flu Vaccine for All Who Want It

Affects about 5 million Americans ... Cymbalta Approved for Fibromyalgia ... Sebelius: There Will Be Swine Flu Vaccine for All Who Want It

In Greece, Italy and Spain Lilly will market the product as Cymbalta(reg) and Boehringer Ingelheim will market the product as Xeristar(reg).

Managing marketed health product-related adverse reactions depends on load area will all members indicate that use of certain medications in your address book.